Revenue surged 39.9% year-over-year, but a large impairment loss led to a net loss of ¥452 million. Full-year guidance was revised upward for revenue but widened for net loss, reflecting acquisition and integration costs.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
